This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, National Institute of Health and Medical Research, University Joseph Fourier (Grenoble 1). Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2015
Title: Danièle Maubon: Innovator in Cyclic Peptides
Introduction
Danièle Maubon is a notable inventor based in Saint Ismier, France. He has made significant contributions to the field of cyclic peptides, particularly in their application as anti-parasitic and anticancer agents. His innovative work has the potential to impact medical treatments significantly.
Latest Patents
Danièle Maubon holds a patent for "Cyclic peptides with an anti-parasitic activity." This invention relates to a method for preparing cyclic peptides that exhibit both antiparasite and anticancer activities. The cyclic peptide developed by Maubon is particularly useful in treating conditions such as toxoplasmosis and can also be employed for treating organs ex vivo before transplantation.
Career Highlights
Throughout his career, Danièle Maubon has worked with prestigious institutions, including the Centre National de la Recherche Scientifique and the National Institute of Health and Medical Research. His work in these organizations has allowed him to advance his research and contribute to significant scientific discoveries.
Collaborations
Danièle has collaborated with esteemed colleagues such as Mohamed-Ali Hakimi and Alexandre Bougdour. These partnerships have enriched his research and expanded the scope of his innovative work.
Conclusion
Danièle Maubon is a distinguished inventor whose work in cyclic peptides showcases his commitment to advancing medical science. His contributions have the potential to lead to significant improvements in treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile